qrp_report
Public
Source
xxxxxxxxxx "info": "By design, individuals stop contributing days at risk during an exposure episode when an HOI occurs. HOIs/Days at-risk metrics reported allow individuals to contribute, at most, one HOI per episode. However, the Query Request Package (QRP) algorithm is able to characterize the number of total HOIs observed during valid treatment episodes. Users can use this field to determine how this characterization should count the number of HOIs",{ "types": [ { "id": "1", "name": "Background Rates (Type 1)", "info": "The background rate cohort identification strategy identifies prevalent or incident use of an event of interest (i.e., exposure to a medical product or occurrence of an HOI) during the user-defined query period" }, { "id": "2", "name": "Exposure and Follow-Up Time (Type 2)", "info": "The exposures and follow-up time cohort creation strategy defines episodes of new use of a medical product of interest and evaluates the occurrence of health outcomes of interest (HOIs)" }, { "id": "3", "name": "Self-Controlled Risk Interval Design (Type 3)", "info": "The self-controlled risk interval (SCRI) design cohort identification strategy defines new use of a medical product of interest, identifies a risk and control window relative to exposure, and examines the occurrence of Health Outcomes of Interest (HOIs)" }, { "id": "4", "name": "Pregnancy Episodes and Medical Product Use (Type 4)", "info": "The pregnancy episodes cohort identification strategy is used to create a pregnant cohort and identify new use of a medical product of interest and evaluates the occurrence of health outcomes of interest (HOIs) in mothers or infants" }, { "id": "5", "name": "Medical Product Utilization (Type 5)", "info": "The medical product utilization cohort identification strategy is used to characterize patterns of drug use. This strategy creates episodes of medical product exposure and outputs metrics characterizing patient use and dispensing patterns" }, { "id": "6", "name": "Manufacturer-Level Product Utilization and Switching Patterns (Type 6)", "info": "The manufacturer-level product utilization and switching patterns cohort identification strategy is used to characterize patterns of drug use at the manufacturer-level" } ], "input_files": [ { "id": "cohortfile", "name": "Cohort File", "analysis_types": [ "1", "2", "3", "4", "5", "6" ], "required": true, "required_files": [], "info": "Used to define enrollment and demographic requirements, select the type of cohort identification strategy for the request, and indicate if extraction should be restricted to individuals for whom medical records may be requested", "documentation_link": "https://dev.sentinelsystem.org/projects/SENTINEL/repos/sentinel-routine-querying-tool-documentation/browse/files/file526-typeall-cohortfile.md", "table_type": "group", "import": false, "row_source": [ "cohort" ], "row_parameter": "cohortgrp", "all_groups_required": true, "parameters": [ { "id": "COHORTGRP", "name": "Cohort", "sas_format": "$40", "info": "Standardized name used to differentiate cohorts", "input_type": "RowParameter", "values": [] }, { "id": "COVERAGE", "name": "Coverage Type Requirement", "sas_format": "$2", "info": "Indicates medical and drug coverage type requirements for the cohort", "input_type": "SingleSelect", "values": [ "M", "D", "MD" ], "value_map": { "M": "Medical Coverage", "D": "Drug Coverage", "MD": "Medical and Drug Coverage" } }, { "id": "ENROLGAP", "name": "Enrollment Gap", "sas_format": "3", "info": "Sets the number of days that will be bridged between two consecutive enrollment periods to create a 'continuously enrolled' period", "input_type": "Numeric", "values": [] }, {